|
|
The biological effects of kidney injury molecule-1 in lipopolysaccharide mediated HK-2 cell inflammatory response |
JIANG Yingying1, CHEN Longwang2, LIN Yue1, CHEN Xinguo1, ZHEGN Yanyan1, LU Zhongqiu2 |
1.Department of Emergency, the Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People’s Hospital, Wenzhou 325000, China; 2.Department of Emergency, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China |
|
Cite this article: |
JIANG Yingying,CHEN Longwang,LIN Yue, et al. The biological effects of kidney injury molecule-1 in lipopolysaccharide mediated HK-2 cell inflammatory response[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(2): 85-90.
|
|
Abstract Objective: To investigate the expression of kidney injury molecule-1 (KIM-1) in lipopolysaccharide (LPS)-induced HK-2 cells and explore the biological process it maybe involved. Methods: Human renal tubular epithelial HK-2 cells were treated with LPS to establish the sepsis-induced renal cell inflammatory model. CCK-8 assay was used to detect the growth inhibition effect of LPS on HK-2 cells. The mRNA and protein expression levels of KIM-1 were detected by RT-PCR and Western blot respectively. The siRNA sequences targeted on KIM-1 gene were designed and tranfected to HK-2 cells, and then the effects of LPS on the growth inhibition of transfected HK-2 cells were detected by CCK-8 assays. Hoechst33342/PI staining was performed to detect the apoptosis in siRNA and control groups. Results: The proliferation of HK-2 cells was inhibited after treatment with LPS at final concentration of 50 μg/mL and 100 μg/mL for 24 h and 48 h, and the differences were statistically significant compared with the control group (P<0.05). The mRNA and protein levels of KIM-1 and IL-6 gene were greatly up-regulated after treatment with LPS in a dose-dependent manner, the differences being statistically significant (P<0.05). The proportion of Hoechst3342 positive cells in LPS treatment group was significantly higher than that in control group. The expression levels of KIM-1 and IL-6 genes in siRNA groups were significantly lower than that in siRNA-NC group, with significant differences (P<0.05); The proliferation rate was significantly higher in siRNA transfection group, compared with the siRNA-NC group, and the differences were statistically significant (P<0.05). The fluorescence intensity of Hoechst3342 staining in siRNA transfection groups was lower than that in siRNA-NC group, suggesting that siRNA transfection targeting on KIM-1 gene could inhibit the apoptosis induced by LPS. Conclusion: LPS can induce the proliferation inhibition and apoptosis of HK-2 cells, and up-regulate the expression of KIM-1 and IL-6 genes. KIM-1 may participate in the inflammatory reaction by regulating the process of apoptosis and cell growth inhibition.
|
|
|
|
|
|
[1] SILVESTER W, BELLOMO R, COLE L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia[J]. Crit Care Med, 2001, 29(10): 1910-1915.
[2] KAPLAN G, TOTSUKA A, THOMPSON P, et al. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus[J]. EMBO J, 1996, 15(16): 4282-4296.
[3] FEIGELSTOCK D, THOMPSON P, MATTOO P, et al. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor[J]. J Virol, 1998, 72(8): 6621-6628.
[4] KIRK R. Renal fibrosis: KIM-1 expression links kidney injury with CKD in mice[J]. Nat Rev Nephrol, 2013, 9(11): 627.
[5] HAN W K, BAILLY V, ABICHANDANI R, et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury[J]. Kidney Int, 2002, 62(1): 237-244.
[6] ICHIMURA T, ASSELDONK E J, HUMPHREYS B D, et al.
Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells[J]. J Clin Invest, 2008, 118(5): 1657-1668.
[7] 王刘伟, 董吉, 房豫东, 等. 肾损伤分子1对高糖诱导大鼠肾小管上皮细胞表达单核细胞趋化蛋白1和纤维连接蛋白的影响[J]. 中华肾脏病杂志, 2014, 30(1): 48-52.
[8] 霍文谦, 靳风烁, 李黔生, 等. 肾小管缺氧损伤中肾损伤分子-1表达信号通路的调节[J]. 肾脏病与透析肾移植杂志, 2011, 20(1): 34-39.
[9] DE BORST M H, VAN TIMMEREN M M, VAIDYA V S, et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase[J]. Am J Physiol Renal Physiol, 2007, 292(1): F313-320.
[10] KOJIMA K, MUSCH M W, ROPELESKI M J, et al. Escherichia coli LPS induces heat shock protein 25 in intestinal epithelial cells through MAP kinase activation[J]. Am J Physiol Gastrointest Liver Physiol, 2004, 286(4): 645-652.
[11] KAO Y H, CHEN P H, WU T Y, et al. Lipopolysaccharides induce Smad2 phosphorylation through PI3K/Akt and MAPK cascades in HSC-T6 hepatic stellate cells[J]. Life Sci, 2017, 184: 37-46.
[12] ROSSA C JR, LIU M, BRONSON P, et al. Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase[J]. J Endotoxin Res, 2007, 13(2): 85-93.
[13] NECHEMIA-ARBELY Y, BARKAN D, PIZOV G, et al. IL-6/IL-6R axis plays a critical role in acute kidney injury[J]. J Am Soc Nephrol, 2008, 19(6): 1106-1115.
[14] KLEIN C L, HOKE T S, FANG W F, et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy[J]. Kidney Int, 2008, 74(7): 901-909.
[15] LEE Y J, HEO J S, SUH H N, et al. Interleukin-6 stimulates alpha-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-kappaB[J]. Am J Physiol Renal Physiol, 2007, 293(4): F1036-F1046.
[16] TONG G, KRAUSS A, MOCHNER J, et al. Deep hypothermia therapy attenuates LPS induced microglia neuroinflammation via the STAT3 pathway[J]. Neuroscience, 2017, 358: 201-210.
[17] LIAO L, ZHANG X D, LI J, et al. Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-κB/IL-6/STAT3, CREB/BDNF pathways and central serotonergic neurotransmission in mice[J]. Int Immunopharmacol, 2017, 49: 178-186.
|
|
|
|